Please assess the completion status of the following clinical trial:

Trial Title: Ketamine Infusion for Treatment-resistant Major Depressive Disorder

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Outpatients with severe treatment-resistant MDD~* Currently depressed~* Currently under regular psychiatric care~* On an aggressive antidepressant regimen, stable for 4 weeks~Exclusion Criteria:~* No history of other major psychiatric illnesses, including bipolar disorder~* No history of psychosis~* No history of drug abuse~* No major medical illness or unstable medical conditions

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Ketamine IV (Type: EXPERIMENTAL): Patients will receive open label augmentation with IV Ketamine at 0.5mg/kg, twice a week for 3 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).